Unknown

Dataset Information

0

Glutamine uptake and catabolism is required for myofibroblast formation and persistence.


ABSTRACT:

Background

Fibrosis and extracellular matrix remodeling are mediated by resident cardiac fibroblasts (CFs). In response to injury, fibroblasts activate, differentiating into specialized synthetic and contractile myofibroblasts producing copious extracellular matrix proteins (e.g., collagens). Myofibroblast persistence in chronic diseases, such as HF, leads to progressive cardiac dysfunction and maladaptive remodeling. We recently reported that an increase in αKG (alpha-ketoglutarate) bioavailability, which contributes to enhanced αKG-dependent lysine demethylase activity and chromatin remodeling, is required for myofibroblast formation. Therefore, we aimed to determine the substrates and metabolic pathways contributing to αKG biosynthesis and their requirement for myofibroblast formation.

Methods

Stable isotope metabolomics identified glutaminolysis as a key metabolic pathway required for αKG biosynthesis and myofibroblast formation, therefore we tested the effects of pharmacologic inhibition (CB-839) or genetic deletion of glutaminase (Gls1-/-) on myofibroblast formation in both murine and human cardiac fibroblasts. We employed immunofluorescence staining, functional gel contraction, western blotting, and bioenergetic assays to determine the myofibroblast phenotype.

Results

Carbon tracing indicated enhanced glutaminolysis mediating increased αKG abundance. Pharmacological and genetic inhibition of glutaminolysis prevented myofibroblast formation indicated by a reduction in αSMA+ cells, collagen gel contraction, collagen abundance, and the bioenergetic response. Inhibition of glutaminolysis also prevented TGFβ-mediated histone demethylation and supplementation with cell-permeable αKG rescued the myofibroblast phenotype. Importantly, inhibition of glutaminolysis was sufficient to prevent myofibroblast formation in CFs isolated from the human failing heart.

Conclusions

These results define glutaminolysis as necessary for myofibroblast formation and persistence, providing substantial rationale to evaluate several new therapeutic targets to treat cardiac fibrosis.

SUBMITTER: Gibb AA 

PROVIDER: S-EPMC10486318 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Glutamine uptake and catabolism is required for myofibroblast formation and persistence.

Gibb Andrew A AA   Huynh Anh T AT   Gaspar Ryan B RB   Ploesch Tori L TL   Lombardi Alyssa A AA   Lorkiewicz Pawel K PK   Lazaropoulos Michael P MP   Bedi Ken K   Arany Zolt Z   Margulies Kenneth B KB   Hill Bradford G BG   Elrod John W JW  

Journal of molecular and cellular cardiology 20220818


<h4>Background</h4>Fibrosis and extracellular matrix remodeling are mediated by resident cardiac fibroblasts (CFs). In response to injury, fibroblasts activate, differentiating into specialized synthetic and contractile myofibroblasts producing copious extracellular matrix proteins (e.g., collagens). Myofibroblast persistence in chronic diseases, such as HF, leads to progressive cardiac dysfunction and maladaptive remodeling. We recently reported that an increase in αKG (alpha-ketoglutarate) bio  ...[more]

Similar Datasets

| S-EPMC10942467 | biostudies-literature
| S-EPMC4754153 | biostudies-literature
| S-EPMC7865731 | biostudies-literature
| S-EPMC9415643 | biostudies-literature
| S-EPMC4660206 | biostudies-literature
| S-EPMC11546858 | biostudies-literature
| S-EPMC4319407 | biostudies-literature
| S-EPMC3272947 | biostudies-literature
2012-12-20 | E-GEOD-35968 | biostudies-arrayexpress
| S-EPMC4646190 | biostudies-literature